# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001130319-08-000302
Filing Date
2008-04-08
Accepted
2008-04-08 16:15:12
Documents
23
Period of Report
2008-04-07

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | o40024e6vk.htm | 6-K | 996987
2 | GRAPHIC | o40024o4002401.gif | GRAPHIC | 168975
3 | GRAPHIC | o40024o4002402.gif | GRAPHIC | 99596
4 | GRAPHIC | o40024o4002416.gif | GRAPHIC | 1285
5 | GRAPHIC | o40024o4002403.gif | GRAPHIC | 2560
6 | GRAPHIC | o40024o4002404.gif | GRAPHIC | 120028
7 | GRAPHIC | o40024o4002417.gif | GRAPHIC | 1674
8 | GRAPHIC | o40024o4002420.gif | GRAPHIC | 2832
9 | GRAPHIC | o40024o4002415.gif | GRAPHIC | 2179
10 | GRAPHIC | o40024o4002405.gif | GRAPHIC | 3744
11 | GRAPHIC | o40024o4002418.gif | GRAPHIC | 1849
12 | GRAPHIC | o40024o4002419.gif | GRAPHIC | 1268
13 | GRAPHIC | o40024o4002406.gif | GRAPHIC | 2688
14 | GRAPHIC | o40024o4002407.gif | GRAPHIC | 1735
15 | GRAPHIC | o40024o4002421.gif | GRAPHIC | 698
16 | GRAPHIC | o40024o4002408.gif | GRAPHIC | 48755
17 | GRAPHIC | o40024o4002400.gif | GRAPHIC | 3922
18 | GRAPHIC | o40024o4002409.gif | GRAPHIC | 5487
19 | GRAPHIC | o40024o4002410.gif | GRAPHIC | 2169
20 | GRAPHIC | o40024o4002411.gif | GRAPHIC | 1471
21 | GRAPHIC | o40024o4002412.gif | GRAPHIC | 2130
22 | GRAPHIC | o40024o4002413.gif | GRAPHIC | 2064
23 | GRAPHIC | o40024o4002414.gif | GRAPHIC | 2545
| Complete submission text file | 0001130319-08-000302.txt |  | 1662613

Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 08745526
SIC: 2834 Pharmaceutical Preparations